SARS-CoV2 Sequencing Surveillance Program for Upstate South Carolina
南卡罗来纳州北部 SARS-CoV2 测序监测计划
基本信息
- 批准号:10691023
- 负责人:
- 金额:$ 67.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAnimal ModelAnimal TestingAnimalsAreaAwardBasic ScienceBioinformaticsBiologyBiomedical EngineeringBiomedical ResearchBone DiseasesCadaverCenters of Research ExcellenceClinicalCollaborationsCommunitiesComplementComputer ModelsDataDevelopmentDevicesDisciplineEvaluationFacultyFaculty RecruitmentFosteringFundingFutureGlossaryGoalsHealthHealth systemHealthcareHumanInfrastructureInterventionInvestmentsMedicalMedical ResearchMedicineMentorsModelingModernizationMusculoskeletalMusculoskeletal DiseasesMusculoskeletal SystemNatureOutcomePatientsPerformancePersonnel RecruitmentsPersonsPhysicsPrecision therapeuticsPrivate SectorProcessPublic HealthPublishingRandomized Clinical TrialsResearchResearch InfrastructureResearch PersonnelResourcesSchoolsShapesSouth CarolinaSpecimenSupercomputingSystems BiologyTechnologyTechnology TransferTestingTherapeuticTherapeutic InterventionTherapeutic UsesTimeTissuesTrainingTranslatingTranslational ResearchTranslationsUnited StatesUnited States National Institutes of HealthUniversitiesValidationWorkacronymsaging populationarthropathiesbasebody systemcareerclinical practicecluster computingcostdisabilityequipment acquisitionflexibilityimprovedin vivoinnovationinterdisciplinary approachinterestmaterials sciencemulti-scale modelingmultidisciplinarynovelnovel strategiesnovel therapeutic interventionpre-clinical assessmentprecision medicineprogramssensor technologyskeletalsuccesssystems researchtechnology developmentvirtual human
项目摘要
Project Summary
The overall objective of this project is to continue and expand surveillance efforts to detect and monitor extant
and emerging variants by sequencing the positive samples detected by the extensive university surveillance and
community testing programs at Clemson University (CU). Variants of concern of SARS-CoV-2 have caused large
outbreak events worldwide. As we tracked during the significant Delta and Omicron outbreaks in Upstate South
Carolina, this poses a serious public health threat; the new variants can escape the coverage of COVID-19
vaccines or infect previously exposed individuals. Our sequencing surveillance program aims to continue to
provide much-needed insight and guidance to inform policy decisions to help mitigate these potential threats.
In response to the COVID-19 pandemic, CU established a robust high-throughput COVID-19 diagnostic testing
program, which enabled the university to remain opened to in-person instruction through most of the pandemic.
The CLIA-certified Clemson Research and Education in Disease Diagnosis and Intervention (REDDI) Lab has
facilitated regular testing of all university personnel and free testing to members of the surrounding Upstate South
Carolina community. The lab has run >10% of all the COVID-19 tests from South Carolina. In 2021, the REDDI
Lab partnered with the CU Genomics and Bioinformatic Facility (CUGBF) to set up a SARS-CoV-2 genomics
sequencing program, which mapped 3 major outbreak events and provided early detection of the Delta and
Omicron variants in the rural Upstate South Carolina region. These data were instrumental to inform the pre-
emptive COVID-19 policies and timely response for the university as well as Upstate SC cities and municipalities.
In addition, the sequencing surveillance program allowed for significant scientific discovery on variant specific
disease presentation, variant differences in effectiveness of vaccine and prior infection protection, surveillance
testing and COVID-19 mitigation strategies, and wastewater community surveillance efforts. The results from
the sequencing program also led to the development of new assays and technologies for COVID-19 diagnosis
and surveillance as well as undergraduate and graduate student training and community outreach programs.
To accomplish our overall goals of continued SARS-CoV-2 genomic surveillance, we propose the following aims:
Aim 1: Determine the association of SARS-CoV-2 genomic variants with population demographics, outbreak
events, COVID-19 symptom severity and duration, previous infection, and vaccination.
Aim 2: Develop real-time workflows and data analytics platforms to meet the challenge of variant surveillance
through the on-going COVID-19 situation for its inevitable transition from pandemic to endemic phase.
Over the last year, we have created a unique and robust sequencing program that not only sequences samples
but also ties the results to a rich university and community COVID-19 surveillance database to enable secure
and effective data mining for continued analysis. Our community testing program has provided testing and
surveillance to remote and underserved areas of the Upstate. This provided for an excellent representation of
the Upstate South Carolina demographics, including significant numbers of patients from populations with known
COVID-19 outcome disparities. Because of the university and our proximity to major travel hubs (e.g.,
Atlanta/Charlotte) there is significant flux of travelers in our area who introduce new variants into our relatively
rural community. Over the past year, we have demonstrated that the SARS-CoV-2 variant prevalence in rural
Upstate SC is distinct from the rest of the state. In addition, our program captured data from patient demographic
groups that are highly under-sampled by other labs at hospitals and public health agencies. The majority of
positive cases detected by our lab were young and usually asymptomatic or minimally symptomatic at the time
of diagnosis. However, we have shown that, particularly with the newer variants of concern, these patients can
readily spread the disease to others and they, themselves, even with mild symptoms, can sometimes have longer
lasting health effects. Overall, this has demonstrated the need for continued SARS-CoV-2 sequencing support
to study the evolving COVID-19 pandemic in our region and for our population groups.
项目摘要
该项目的总体目标是继续并扩大监测工作,
通过对广泛的大学监测检测到的阳性样本进行测序,
克莱姆森大学(CU)的社区测试项目。SARS-CoV-2的变异引起了大量的关注,
全球爆发事件。正如我们在南部北部的三角洲和奥米克戎爆发期间所追踪的那样
在卡罗莱纳,这构成了严重的公共卫生威胁;新的变种可以逃脱COVID-19的覆盖范围
疫苗或感染以前接触过的人。我们的测序监测计划旨在继续
提供急需的洞察力和指导,为政策决策提供信息,以帮助缓解这些潜在威胁。
为应对COVID-19疫情,中大建立了强大的高通量COVID-19诊断检测
该计划使该大学能够在大流行期间的大部分时间内保持对面对面教学的开放。
CLIA认证的克莱姆森疾病诊断和干预研究和教育(REDDI)实验室
促进了所有大学人员的定期测试和免费测试,以周围的北部南部的成员
卡罗莱纳社区。该实验室已经运行了来自南卡罗来纳州的所有COVID-19测试的10%以上。2021年,REDDI
实验室与CU基因组学和生物信息学设施(CUGBF)合作,建立了SARS-CoV-2基因组学
测序计划,该计划绘制了3个主要爆发事件,并提供了三角洲的早期检测,
南卡罗来纳州北部农村地区的奥密克隆变种。这些数据有助于告知前-
积极的COVID-19政策和及时的反应,为大学以及北南卡罗来纳州的城市和市政当局。
此外,测序监测计划允许在变异特异性上的重大科学发现。
疾病表现、疫苗有效性和既往感染保护的变异差异、监测
测试和COVID-19缓解策略,以及废水社区监测工作。的结果
测序计划还导致了新的COVID-19诊断方法和技术的发展
以及本科生和研究生培训和社区外展计划。
为了实现我们持续SARS-CoV-2基因组监测的总体目标,我们提出了以下目标:
目的1:确定SARS-CoV-2基因组变异与人口统计学特征、疫情暴发
事件、COVID-19症状严重程度和持续时间、既往感染和疫苗接种。
目标2:开发实时工作流程和数据分析平台,以应对变异监测的挑战
持续的2019冠状病毒病疫情不可避免地从大流行阶段过渡到地方流行阶段。
在过去的一年里,我们创建了一个独特而强大的测序程序,不仅可以对样本进行测序,
而且还将结果与丰富的大学和社区COVID-19监测数据库联系起来,
和有效的数据挖掘进行持续分析。我们的社区测试计划提供了测试和
监控到偏远和服务不足的地区北部。这是一个很好的代表性,
南卡罗来纳州北部的人口统计学数据,包括来自已知
COVID-19结果差异。由于大学和我们靠近主要的旅游中心(例如,
亚特兰大/夏洛特)在我们地区有大量的旅行者,他们将新的变体引入我们相对
农村社区。在过去的一年里,我们已经证明了SARS-CoV-2变异在农村的流行,
上州SC与该州其他地区不同。此外,我们的程序从患者人口统计学中获取数据,
医院和公共卫生机构的其他实验室对这些群体的抽样严重不足。大多数
我们实验室检测到的阳性病例都是年轻人,当时通常没有症状或症状轻微
诊断。然而,我们已经证明,特别是对于新的变异,这些患者可以
很容易将疾病传播给他人,他们自己,即使症状轻微,有时也会有更长的时间
持久的健康影响。总的来说,这表明需要持续的SARS-CoV-2测序支持
研究我们地区和我们人群中不断演变的COVID-19大流行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hai Yao其他文献
Hai Yao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hai Yao', 18)}}的其他基金
SARS-CoV2 sequencing surveillance program for Upstate South Carolina
南卡罗来纳州北部 SARS-CoV2 测序监测计划
- 批准号:
10381278 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)
SC COBRE 用于改善肌肉骨骼健康的转化研究 (SC-TRIMH)
- 批准号:
10400367 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
Multi-Scale Computational Modeling Core (MCM)
多尺度计算建模核心 (MCM)
- 批准号:
10714164 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)
SC COBRE 用于改善肌肉骨骼健康的转化研究 (SC-TRIMH)
- 批准号:
10244913 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)
SC COBRE 用于改善肌肉骨骼健康的转化研究 (SC-TRIMH)
- 批准号:
10854267 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
SC COBRE for TranslationalResearch Improving MusculoskeletalHealth (SC-TRIMH)
SC COBRE 改善肌肉骨骼健康转化研究 (SC-TRIMH)
- 批准号:
10714162 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)
SC COBRE 用于改善肌肉骨骼健康的转化研究 (SC-TRIMH)
- 批准号:
10582104 - 财政年份:2018
- 资助金额:
$ 67.3万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 67.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




